Literature DB >> 12070059

Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate.

Aaron Deykin1, Anthony F Massaro, Jeffrey M Drazen, Elliot Israel.   

Abstract

Measurement of the fraction of exhaled nitric oxide (FENO) has been proposed as a noninvasive assessment of asthmatic airway inflammation. The influence of the expiratory flow rate during the collection maneuver on the ability of FENO to discriminate healthy subjects from those with asthma is unknown. We compared online and offline measurement of FENO at different flow rates. FENO was collected with expiratory flows of 50-500 ml/second in 34 patients with asthma (PC(20) of less than 8 mg/ml) and 28 healthy subjects (PC(20) of more than 10 mg/ml) using offline collection techniques. In a subgroup of 18 individuals with asthma and 17 healthy subjects, we additionally measured FENO at multiple expiratory flow rates (47-250 ml/second) using online methods. FENO fell with an increasing expiratory flow rate; FENO was higher in subjects with asthma as compared with healthy subjects at each flow rate studied with both techniques (p < 0.001). Receiver operating characteristic (ROC) curves for the diagnosis of asthma indicated that FENO is a robust discriminator between individuals with asthma and healthy subjects (area under the ROC curves 0.79 +/- 0.06 to 0.86 +/- 0.06, p for significant discrimination < 0.0001). Neither expiratory flow rate nor collection technique (online versus offline) significantly altered this discriminatory capacity (area under the ROC curves = 0.84 +/- 0.07 with the slowest online method versus 0.80 +/- 0.07 with the fastest offline method, p = 0.46). These data indicate that the choice of expiratory flow rate and collection method can be based on practicality and patient comfort without compromising the utility of this test for asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070059     DOI: 10.1164/rccm.2201081

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

1.  Exhaled nitric oxide: sources of error in offline measurement.

Authors:  William S Linn; Marisela Avila; Henry Gong
Journal:  Arch Environ Health       Date:  2004-08

2.  Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests.

Authors:  N Berkman; A Avital; R Breuer; E Bardach; C Springer; S Godfrey
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

Review 3.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 5.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

6.  Heart Rate Variability Biofeedback Does Not Substitute for Asthma Steroid Controller Medication.

Authors:  Paul M Lehrer; Charles G Irvin; Shou-En Lu; Anthony Scardella; Beatrix Roehmheld-Hamm; Milisyaris Aviles-Velez; Jessica Graves; Evgeny G Vaschillo; Bronya Vaschillo; Flavia Hoyte; Harold Nelson; Frederick S Wamboldt
Journal:  Appl Psychophysiol Biofeedback       Date:  2018-03

7.  FE NO concentrations in World Trade Center responders and controls, 6 years post-9/11.

Authors:  Matthew P Mauer; Rebecca Hoen; David Jourd'heuil
Journal:  Lung       Date:  2011-06-12       Impact factor: 2.584

8.  Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma.

Authors:  Lanlan Zhang; Jin Gang; Cao Zhigang; Cui Yali; Shen Baozhong; Zhang Fangbiao; Chuntao Liu
Journal:  Wien Klin Wochenschr       Date:  2014-08-20       Impact factor: 1.704

Review 9.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

10.  Exhaled nitric oxide in stable chronic obstructive pulmonary disease.

Authors:  Mohammed F S Beg; Mohammad A Alzoghaibi; Abdullah A Abba; Syed S Habib
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.